Regulated information
March 8, 2012
TiGenix to announce 2011 results on March 15
Leuven (BELGIUM)Â -Â March 8, 2012Â -Â TiGenix (NYSEÂ Euronext: TIG)Â announced
today the Company will issue its full-year 2011 results at 7:00 CET on March
15, followed by a discussion of the results and a business update in a
conference call at 15:00 CET.
Title:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â TiGenix Full-Year 2011 Financial Results
Date:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â March 15, 2012
Time:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 15:00 CET (14:00 GMT/9:00 EST)
To participate, please listen to the webcast or call one of the following
telephone numbers.
International dial-in numbers:
                       +32 2 620 0138                     Belgium
                       +34 91 791 7146                   Spain
                       +31 20 721 9158                   Netherlands
                       +44 20 3106 4822                UK
                       +1 646 254 3388                   USA
For more information:
Hans Herklots
Director Investor & Media Relations
hans.herklots@tigenix.com
+32 16 39 79 73
About TiGenix
TiGenix NV (NYSE Euronext Brussels: TIG)Â is a leading European cell therapy
company with two marketed products for cartilage repair, and a strong pipeline
with clinical stage allogeneic adult stem cell programs for the treatment
of autoimmune and inflammatory diseases. TiGenix is based out of Leuven
(Belgium) and has operations in Madrid (Spain), Cambridge (UK) and Sittard-
Geleen (the Netherlands). For more information please visit www.tigenix.com.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: TiGenix via Thomson Reuters ONE
[HUG#1592386]
